Antibody acquisition after second and third SARS-CoV-2 vaccinations in Japanese kidney transplant patients: a prospective study-Reference-Cited by-同舟云学术

Antibody acquisition after second and third SARS-CoV-2 vaccinations in Japanese kidney transplant patients: a prospective study

Published:2023-03-13 Issue:6 Volume:27 Page:574-582
ISSN:1342-1751
Container-title:Clinical and Experimental Nephrology
language:en
Short-container-title:Clin Exp Nephrol

Author:

Deguchi Hidetaka,Sakamoto Atsuhiko,Nakamura Nobuyuki,Okabe Yasuhiro,Miura Yoshifumi,Iida Takeshi,Yoshimura Michinobu,Haga Nobuhiro,Nabeshima Shigeki,Masutani Kosuke^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Nephrology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10157-023-02334-0.pdf

Reference27 articles.

1. Chu L, McPhee R, Huang W, et al. A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine. Vaccine. 2021;39:2791–9.

2. Müller L, Andrée M, Moskorz W, et al. Age-dependent immune response to the Biontech/Pfizer BNT162b2 coronavirus disease 2019 vaccination. Clin Infect Dis. 2021;73:2065–72.

3. Terpos E, Trougakos IP, Apostolakou F, et al. Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine. Am J Hematol. 2021;96:E257–9.

4. Bayart JL, Morimont L, Closset M, et al. Confounding factors influencing the kinetics and magnitude of serological response following administration of BNT162b2. Microorganisms. 2021;9:1340.

5. Kageyama T, Ikeda K, Tanaka S, et al. Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan. Clin Microbiol Infect. 1861;2021(27):e1-5.